Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
更正：NSABP FB-7：一项针对HER2阳性乳腺癌患者的II期随机新辅助治疗试验，采用紫杉醇联合曲妥珠单抗和/或奈拉替尼，随后进行化疗和术后曲妥珠单抗治疗。
期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-019-1240-y
Jacobs, Samuel A; Robidoux, André; Abraham, Jame; Pérez-Garcia, José Manuel; La Verde, Nicla; Orcutt, James M; Cazzaniga, Marina E; Piette, Fanny; Antolín, Silvia; Aguirre, Elena; Cortes, Javier; Llombart-Cussac, Antonio; Di Cosimo, Serena; Kim, Rim S; Feng, Huichen; Lipchik, Corey; Lucas, Peter C; Srinivasan, Ashok; Wang, Ying; Song, Nan; Gavin, Patrick G; Balousek, April D; Paik, Soonmyung; Allegra, Carmen J; Wolmark, Norman; Pogue-Geile, Katherine L
